Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Are There Differences in 2-Year Outcomes Between Two-Level Anterior Cervical Diskectomy and Fusion Versus Single-Level Anterior Cervical Corpectomy and Fusion to Treat Cervical Myelopathy? A Quality Outcomes Database Study
Berlin, Connor , Mummaneni, Praveen V., Chan, Andrew K. , Chou, Dean , Fu, Kai-Ming, Bydon, Mohamad , Bisson, Erica F. , Shaffrey, Christopher I. , Gottfried, Oren N., Asher, Anthony L. , Coric, Domagoj , Potts, Eric A. , Foley, Kevin T. , Wang, Michael Y. , Virk, Michael S. , Knightly, John J. , Meyer, Scott A., Upadhyaya, Cheerag D., Tumialán, Luis M. , Turner, Jay D. , Uribe, Juan S. , Haid, Regis W., Yen, Chun-Po , Shaffrey, Mark E., Shaffrey, Mark E , Ibrahim, Sufyan , Mummaneni, Praveen V. , Park, Paul

Mayo Clinic

Neurosurgery | May 19, 2025 | Volume: 97 | Issue: 5 | Pages: 1091-1099

10.1227/neu.0000000000003518 | PMID 40388528 Get It

BACKGROUND AND OBJECTIVES: There has been limited assessment between anterior cervical diskectomy and fusion (ACDF) and anterior cervical corpectomy and fusion (ACCF) on patient-reported outcome measures (PROMs) in the treatment of cervical spondylotic myelopathy. We sought to compare PROMs from two-level ACDF with single-level ACCF procedures. We evaluate these results in the context of minimum clinically important difference (MCID) thresholds, which have not been performed previously. METHODS: This retrospective analysis of prospectively collected data from the Quality Outcomes Database Spine Collaborative Research Study Group compared two-level ACDF and single-level ACCF at 3-, 12-, and 24 months postoperatively. PROMs included arm pain Numeric Rating Scale, neck pain Numeric Rating Scale, Neck Disability Index, and North American Spine Society Patient Satisfaction Index. Multivariate logistic regression was used to determine differences in perioperative outcomes, as well as the impact of two-level ACDF vs one-level ACCF on PROMs. MCID thresholds were based off previously established limits. RESULTS: Three hundred and thirty patients were included (236 ACDF, 94 ACCF), and the follow-up rate was 82% at 2 years. There was a significantly higher baseline age, American Society of Anesthesiologists grade, proportion of diabetes, osteoarthritis, ambulation dependence, and myelopathy severity in the ACCF cohort. On multivariable analysis, the ACCF group had greater average length of stay and estimated blood loss. There were no significant differences between reoperation rates or nonroutine discharge. There were similar rates of MCID achievement for PROMs at all time points. CONCLUSION: This study suggests that both ACDF and ACCF procedures for cervical spondylotic myelopathy are able to achieve similar, clinically meaningful improvements in PROMs by 2 years. Patients undergoing single-level ACCF have more estimated blood loss and longer length of stay, as well as worse baseline myelopathy. Both procedures have efficacious, durable outcomes. It is reasonable that other factors, such as radiographic characteristics and patient symptoms, may influence patient selection for ACDF vs ACCF.
AI-Augmented authorship: revolutionizing histopathology publishing in the generative AI era
Gu, Qiangqiang , Li, Nianyi , Littlefield, Nickolas , Gao, Fengyi , Saini, Monika Lamba , Wang, Yongfu , Wheeler, Bradley J. , Soong, T. Rinda , Xia, Rong , Tafti, Ahmad P

Mayo Clinic

Journal of Histotechnology | May 19, 2025 | Volume: 48 | Issue: 2 | Pages: 79-81

10.1080/01478885.2025.2505294 | PMID 40384404 Get It

Federated Learning for Renal Tumor Segmentation and Classification on Multi‐Center MRI Dataset
Nguyen, Dat‐Thanh , Imami, Maliha , Zhao, Linmei , Wu, Jing , Borhani, Ali , Khunte, Mihir , Zhong, Zhusi , Shi, Victoria, Yao, Sophie, Wang, Yuli , Loizou, Nicolas , Silva, Alvin C. , Zhang, Paul J. , Zhang, Zishu , Kamel, Ihab R. , Liao, Weihua , Bai, Harrison X. , Bai, Harrison X. , Kamel, Ihab R , Mohseni, Alireza , Yao, Sophie, Jiao, Zhicheng

Mayo Clinic

Journal of Magnetic Resonance Imaging | May 19, 2025 | Volume: 62 | Issue: 3 | Pages: 814-824

10.1002/jmri.29819 | PMID 40384349 Get It

ABSTRACTBackgroundDeep learning (DL) models for accurate renal tumor characterization may benefit from multi‐center datasets for improved generalizability; however, data‐sharing constraints necessitate privacy‐preserving solutions like federated learning (FL).PurposeTo assess the performance and reliability of FL for renal tumor segmentation and classification in multi‐institutional MRI datasets.Study TypeRetrospective multi‐center study.PopulationA total of 987 patients (403 female) from six hospitals were included for analysis. 73% (723/987) had malignant renal tumors, primarily clear cell carcinoma (n = 509). Patients were split into training (n = 785), validation (n = 104), and test (n = 99) sets, stratified across three simulated institutions.Field Strength/SequenceMRI was performed at 1.5 T and 3 T using T2‐weighted imaging (T2WI) and contrast‐enhanced T1‐weighted imaging (CE‐T1WI) sequences.AssessmentFL and non‐FL approaches used nnU‐Net for tumor segmentation and ResNet for its classification. FL‐trained models across three simulated institutional clients with central weight aggregation, while the non‐FL approach used centralized training on the full dataset.Statistical TestsSegmentation was evaluated using Dice coefficients, and classification between malignant and benign lesions was assessed using accuracy, sensitivity, specificity, and area under the curves (AUCs). FL and non‐FL performance was compared using the Wilcoxon test for segmentation Dice and Delong's test for AUC (p < 0.05).ResultsNo significant difference was observed between FL and non‐FL models in segmentation (Dice: 0.43 vs. 0.45, p = 0.202) or classification (AUC: 0.69 vs. 0.64, p = 0.959) on the test set. For classification, no significant difference was observed between the models in accuracy (p = 0.912), sensitivity (p = 0.862), or specificity (p = 0.847) on the test set.Data ConclusionFL demonstrated comparable performance to non‐FL approaches in renal tumor segmentation and classification, supporting its potential as a privacy‐preserving alternative for multi‐institutional DL models.Evidence Level4.Technical EfficacyStage 2.
A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on Management of Primary Aldosteronism
Farah, Magdoleen H. , Hegazi, Moustafa , Abusalih, Mohamed , Saadi, Samer , Al-Kordi, Mohammad, Elsheikh, Arwa Mahmoud, Hassett, Leslie, Bancos, Irina , Murad, M Hassan , Saadi, Samer , Farah, Magdoleen H , Abusalih, Mohamed , Firwana, Mohammed , Wang, Zhen , Hassett, Leslie C. , Bancos, Irina , Murad, M. Hassan

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 15, 2025 | Volume: 110 | Issue: 9 | Pages: e2833-e2844

10.1210/clinem/dgaf290 | PMID 40658500 Get It

Abstract Context Primary aldosteronism (PA) is a leading endocrine cause of secondary hypertension. Objective To support the development of the Endocrine Society Clinical Practice Guideline on managing PA. Data Source MEDLINE, Embase, Scopus, and others were searched on October 4, 2024. Study Selection Studies were selected by pairs of independent reviewers. Data Extraction Data were extracted and appraised by pairs of independent reviewers. Data Synthesis We included 95 studies (7 randomized trials and 88 observational studies). We did not identify trials that evaluated the outcomes of PA screening. One observational study suggested that screening was associated with higher rates of using PA-specific medical therapies and better blood pressure control. Patients managed with adrenal venous sampling (vs computed tomography alone) may have a better post-adrenalectomy biochemical cure rate, but with an increased risk of adrenal hemorrhage. Two small observational studies suggested that PA-specific medical or surgical therapy was likely associated with better blood pressure control than nonspecific therapy. Small randomized trials suggested that surgical therapy may be associated with better blood pressure control than medical therapy, with a lower number and dosage of antihypertensive medications. Compared to eplerenone, spironolactone may be associated with better control of hypokalemia and a lower number and dosage of antihypertensive agents. Unsuppressed plasma renin activity was associated with better control of hypokalemia, while suppression was associated with higher risk of mortality, atrial fibrillation, and stroke (very low certainty). Conclusion This systematic review addresses various aspects of managing PA and will support the development of the Endocrine Society guidelines.
Expert Strategies: Skull Base Reconstruction—Global Perspectives, Insights, and Algorithms through a Mixed Methods Approach
Talati, Vidit , Patel, Jagatkumar A. , Nguyen, Theodore V. , Pang, Jonathan C. , Liu, Lauren , Craig, John R. , Papagiannopoulos, Peter , Phillips, Katie M. , Tajudeen, Bobby A. , Adappa, Nithin D. , Sedaghat, Ahmad R. , Anand, Vijay K. , Batra, Pete S., Bergsneider, Marvin, Casiano, Roy R. , Cavallo, Luigi Maria , Cohen, Marc A. , Eloy, Jean Anderson , Evans, James J., Fernandez‐Miranda, Juan C. , Ferrari, Marco , Froelich, Sébastien , Gardner, Paul A. , Gray, Stacey T. , Hanna, Ehab Y., Harvey, Richard J. , Hong, Sang Duk , Hwang, Peter H. , Kong, Doo‐Sik , Lan, Ming‐Ying , Lee, John Y. K. , Levine, Corinna G. , Meço, Cem , Nicolai, Piero, Nyquist, Gurston , Omura, Kazuhiro , Patel, Zara M. , Celda, María Peris, Prevedello, Danny M., Rabinowitz, Mindy, Raza, Shaan M., Sargi, Zoukaa , Schlosser, Rodney J. , Schwartz, Theodore H. , Sindwani, Raj , Stamm, Aldo Cassol , Thorp, Brian D. , Wang, Marilene B. , Wang, Wei‐Hsin , Witterick, Ian , Won, Tae‐Bin , Woodworth, Bradford A. , Wormald, Peter‐John, Zada, Gabriel , Su, Shirley Y. , Kuan, Edward C , Talati, Vidit , Nguyen, Theodore V , Pang, Jonathan C , Craig, John R , Sedaghat, Ahmad R , Wang, Eric W , Ferrari, Marco , Georgalas, Christos , Harvey, Richard J , Hwang, Peter H , Lan, Ming-Ying , Omura, Kazuhiro , Patel, Zara , Neto, Carlos Pinheiro, Schlosser, Rodney J , Snyderman, Carl H , Woodworth, Bradford A , Meço, Cem , Su, Shirley Y , Abiri, Arash , Goshtasbi, Khodayar , Adappa, Nithin D. , Bergsneider, Marvin , Bernal‐Sprekelsen, Manuel , Bleier, Benjamin S. , Cappabianca, Paolo , Carrau, Ricardo L. , Castelnuovo, Paolo , Dallan, Iacopo , El‐Sayed, Ivan H. , Hanna, Ehab Y., Kelly, Daniel F. , Liu, James K. , Locatelli, Davide , McKean, Erin L. , Nicolai, Piero , Passeri, Thibault , Pinheiro‐Neto, Carlos , Prevedello, Danny M., Recinos, Pablo F. , Rosen, Marc R , Turri‐Zanoni, Mario , Wormald, Peter‐John

Mayo Clinic

International Forum of Allergy & Rhinology | May 15, 2025 | Volume: 15 | Issue: 10 | Pages: 1032-1069

10.1002/alr.23596 | PMID 40371737 Get It

ABSTRACT Objective There is limited consensus on endoscopic skull base surgery (ESBS) reconstruction principles. This study aims to generate comprehensive themes regarding ESBS reconstruction by pooling the experiences of ESBS experts, with comparison to a literature review of current published evidence. Methods Structured qualitative interviews of ESBS experts regarding postoperative management and reconstruction of various defect locations were conducted. Results A total of 68 experts comprising 40 academic teams across 13 countries with an average of 18 years of ESBS experience were included. We propose 10 stepwise algorithms for common skull base reconstruction scenarios based on these expert interviews. When available, the nasoseptal flap is used for all high_flow cerebrospinal leak defects. Multilayered reconstruction is favored at all anatomical subsites with increasing number of layers for increasing defect size and complexity. Heterogeneity exists in terms of inlay technique and materials, free grafting versus various pedicled flap options for low‐flow defects or in the absence of a nasal septum, nasal packing, tissue sealant, lumbar drain use, and postoperative management. Commonalities and discrepancies between experts were summarized. Conclusion Skull base reconstruction and post‐ESBS management is highly complex with a wide variety of practice patterns and expert strategies. Further research of higher quality evidence is warranted to identify optimal management patterns, though the current work aims to inform surgeons on these controversial areas by drawing from numerous experiences.
Amyloid beta peptides inhibit glucose transport at the blood-brain barrier by disrupting the insulin-AKT pathway
Wang, Lushan , Curran, Geoffry L., Zhong, Rui , Zheng, Xue , Veerareddy, Vaishnavi, Thieschafer, Josslen S., Min, Hoon‐Ki , Lowe, Val J. , Kandimalla, Karunya K. , Kandimalla, Karunya K , Min, Hoon-Ki Paul , Xue, Zheng, Li, Ling

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | May 15, 2025 | Volume: 45 | Issue: 10 | Pages: 1961-1979

10.1177/0271678x251332493 | PMID 40370301 Get It

Abstract Molecular mechanisms underlying disruptions in brain glucose uptake and metabolism, linked with cognitive decline in Alzheimer’s disease (AD) patients, are only partially understood. This study investigated how soluble amyloid beta (sAβ) peptides affect glucose transport at the blood-brain barrier (BBB), the primary portal for glucose entry into the brain. We demonstrated that [ 18 F]-fluorodeoxyglucose ( 18 FDG) uptake is reduced in sAβ overproducing APP,PS1 transgenic mice compared to wild-type mice. Moreover, the influx rate of 18 FDG decreased in sAβ40 or sAβ42 pre-infused mice, highlighting the inhibitory effect of sAβ peptides on glucose transport at the BBB. Consistently, the expression of GLUT1, the primary glucose transporter at the BBB, is reduced in polarized human cerebral microvascular endothelial cell (hCMEC/D3) monolayers upon exposure to sAβ peptides and in Aβ-laden cerebral vasculature in vivo. The study further examined the influence of sAβ on the insulin-AKT pathway, known to regulate glucose uptake through modulation of thioredoxin-interacting protein (TXNIP) expression. Results showed that sAβ peptides suppress AKT phosphorylation and reduce GLUT1 expression by upregulating TXNIP levels in hCMEC/D3 monolayers. Co-incubation of resveratrol with sAβ peptides reduced TXNIP expression and rectified reductions in GLUT1 expression. In summary, toxic sAβ impairs BBB glucose transport by disrupting the insulin/AKT/TXNIP axis.
Urogynecologic Symptoms Are Not Specific to Anatomic Region of Digestive Symptoms
Sal‐Markar, Tatini, Ghosh, Debolina, Ramanujan, Suruchi , Wang, Xiao Jing , Luo, Yuying , Wang, Xiao Jing , Luo, Yuying , Simons, Madison

Mayo Clinic

Neurogastroenterology & Motility | May 14, 2025 | Volume: 37 | Issue: 11 | Pages: No page available

10.1111/nmo.70081 | PMID 40364465 Get It

ABSTRACTBackground/AimsMany patients with digestive symptoms describe underlying urinary or gynecologic symptoms, which may increase visceral sensitivity in the abdominopelvic region and amplify distress around digestive symptoms. The aim of this study was to describe the prevalence of urinary and gynecologic symptoms in patients with disorders of gut–brain interaction (DGBI).MethodsConsecutive adult patients with a female reproductive tract who were referred for GI behavioral medicine evaluation for DGBI at a tertiary care center between 2022 and 2023 were prospectively evaluated for symptoms associated with urinary and gynecologic dysfunction. Descriptive statistics were conducted to assess the prevalence of these symptoms within this population by anatomic region affected (esophagus, stomach, and bowel).ResultsA total of 432 patients were included in our cohort with a mean (SD) age of 40.0 years [Q1;Q3 29.0–52.0], with a predominantly White population (86.1%). Dysmenorrhea (61.0%) and menorrhagia (58.6%) were commonly reported among women with digestive symptoms. Urinary symptoms were less common, with 18.7% reporting pain with urination, 33.0% reporting difficulty voiding urine, and 26.1% reporting a history of frequent UTIs. 23% of women experienced ≥ 4 urinary/gynecologic symptoms. There were no significant differences in the type of urogynecologic symptoms reported based on the affected area of the GI tract.ConclusionUrogynecologic symptoms are common among patients with DGBIs affecting the entirety of the GI tract. We presume the presence of these comorbid symptoms is likely to impact symptom severity, quality of life, and could affect treatment response. Future studies are necessary to understand the mechanisms behind these shared conditions as well as develop effective treatments that address their overlap.
Matching Patients with Surgeons: Heterogeneous Effects of Surgical Volume on Surgery Duration
Pourghannad, Behrooz , Wang, Guihua

Mayo Clinic

Manufacturing & Service Operations Management | May 13, 2025 | Volume: 27 | Issue: 4 | Pages: 1037-1052

10.1287/msom.2023.0019 Get It

Problem definition: We study how to leverage patient-specific information to improve a hospital’s operational efficiency. We use abdominal surgery as the clinical setting and study the heterogeneous effects of surgical volume on surgery duration. We develop a framework for using patient-specific information by addressing three important questions: (1) Is the effect of surgical volume heterogeneous across patients with different features? (2) If so, how could patient-specific information that captures the heterogeneous effects of surgical volume on surgery duration be generated? (3) What is the value of patient-specific information in helping a hospital improve its operational efficiency? Methodology/results: Using an instrumental variable approach to address potential endogeneity issues, we first use a regression model to show that the average effect of surgical volume on surgery duration is significant. Then, we use a regression model with interaction terms to show that the effect of surgical volume is heterogeneous. After that, we apply an instrumental variable forest approach to obtain patient-specific volume effects. Finally, we use patient-specific volume effects and an optimization model to assess the potential value of patient-specific information in improving a hospital’s operational efficiency. We find the that total duration of surgeries could be reduced by 2.5%–8.9% if patient-specific volume effects are considered. Managerial implications: This study provides a framework for understanding treatment effect heterogeneity and using patient-specific information to improve a hospital’s operational efficiency. We provide empirical evidence that the effect of surgical volume is heterogeneous and address the challenges of estimating heterogeneous effects for different patients. Our framework can help hospital administrators to better match patients with surgeons, improving a hospital’s operational efficiency. Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2023.0019 .
Core GRADE 4: rating certainty of evidence—risk of bias, publication bias, and reasons for rating up certainty
Guyatt, Gordon , Eachempati, Prashanti, Hultcrantz, Monica , Chu, Derek K. , Flórez, Iván D. , Agoritsas, Thomas , Yao, Liang , Vandvik, Per Olav , Brignardello‐Petersen, Romina , Guyatt, Gordon , Chu, Derek K , Wang, Ying , Eachempati, Prashanti , Iorio, Alfonso , Murad, M. Hassan , Hemkens, Lars G. , Montori, Víctor M.

Mayo Clinic

BMJ | May 13, 2025 | Volume: 389 | Issue: No issue available | Pages: e083864

10.1136/bmj-2024-083864 | PMID 40360206 Get It